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ABSTRACT 
 
 
 
 
Colorectal cancer is a malignant tumor arising from the inner wall of the large 
intestine, which is the third most common type of cancer. American Cancer Society 
estimates about 93,090 new cases and 49,700 deaths due to colorectal cancer in the 
United States since 2015. Diet is thought to have a major role in the etiology of 
colorectal cancer. Scientists explore the phenolic phytochemicals found in various 
food substances for colorectal cancer treatment and prevention. In this research, a diet-
derived phenolic compound Gallic Acid (GA) was explored for its antiproliferative 
action against the colon cancer cell line HCT-15. MTT assay results illustrated that 
GA has an inhibitory effect on HCT-15 with IC50 value of 740 μmol/L. A time-
dependent inhibition of colony formation was evident with GA treatment as the 
maximum number of colonies formed was about 110 after 48 h. Cell cycle arrest was 
evident from the accumulation of GA treated HCT-15 cells at sub-G1 phase (0.98±1.03 
vs 58.01±2.05) with increasing exposure time. Flow cytometric analysis of GA treated 
HCT-15 cells depicted various events associated with apoptosis like lipid layer 
breakage and reduction in mitochondrial membrane potential apart from an increase 
in the generation of ROS, which were in a time dependent manner. SEM and 
photomicrograph images of the GA-treated cells displayed membrane blebbing and 
cell shrinking characteristics of apoptosis. Further, the Yo-Pro-1 staining of GA treated 
cells confirmed apoptosis in a time dependent manner. These results propel the role of 
GA as a putative agent in colon cancer treatment. However, further experiments in 
preclinical and clinical settings are required to promote GA as a likely candidate for 
chemotherapy of colon cancer. 
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ABSTRAK 
 
 
 
 
Kanser kolorektal adalah tumor malignan yang timbul daripada dinding dalam 
usus besar, yang merupakan jenis yang ketiga paling umum kanser. Anggaran 
Persatuan Kanser Amerika tentang 93,090 kes baru dan 49,700 kematian akibat kanser 
kolorektal di Amerika Syarikat sejak tahun 2015. Diet dianggap sebagai mempunyai 
peranan utama dalam etiologi kanser kolorektal. Para saintis meneroka fitokimia 
fenolik didapati dalam pelbagai bahan makanan untuk rawatan kanser kolorektal dan 
pencegahan. Dalam kajian ini, diet yang diperolehi sebatian fenolik Gallic Acid (GA) 
telah diterokai untuk tindakan antiproliferative terhadap garis sel kanser usus besar 
HCT-15. Keputusan MTT assay digambarkan bahawa GA mempunyai kesan yg 
melarang pada HCT-15 dengan nilai IC50 740 μmol / L. A perencatan masa yang 
bergantung kepada pembentukan koloni terbukti dengan rawatan GA sebagai bilangan 
maksimum jajahan dibentuk adalah kira-kira 110 selepas 48 h. Kitaran sel 
penangkapan terbukti daripada pengumpulan GA dirawat HCT-15 sel-sel pada fasa 
sub-G1 (0.98 ± 1.03 vs 58.01 ± 2.05) dengan meningkatkan masa pendedahan. Aliran 
analisis cytometric GA dirawat HCT-15 sel-sel yang digambarkan pelbagai acara yang 
berkaitan dengan apoptosis seperti kerosakan lapisan lipid dan pengurangan potensi 
membran mitokondria selain peningkatan dalam penjanaan ROS, yang dengan cara 
yang bergantung kepada masa. SEM dan photomicrograph imej sel GA dirawat 
dipaparkan blebbing membran dan ciri-ciri sel pengecutan apoptosis. Di samping itu, 
Yo-Pro-1 mengotorkan GA dirawat sel-sel yang disahkan apoptosis dengan cara yang 
bergantung kepada masa. Keputusan ini melonjakkan peranan GA sebagai ejen diduga 
dalam rawatan kanser kolon. Walau bagaimanapun, eksperimen lanjut dalam tetapan 
pra-klinikal dan klinikal diperlukan untuk menggalakkan GA sebagai calon mungkin 
untuk kemoterapi kanser kolon. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background 
 
 
Cancer has become a major concern around the globe. Cancer is the second 
major cause of death worldwide (Bernard et al., 2014), which is a class of diseases 
characterized by uncontrolled cell proliferation. At present, cancer is the cause of 1 
in every 7 deaths worldwide.  The burden is mounting at a rapid level, around 21.7 
million new cancer cases and 13.0 million cancer deaths are expected in the year 
2030 due to varying daily habits. The change in lifestyle (such as smoking, 
unbalanced diet, physical inactivity, reproductive patterns) associated in the 
developing countries are other factors that add fuel to this problem. As diet plays a 
crucial role in causing as well as preventing cancer, the field of investigations on the 
role of nutrition and cancer is ruthlessly broad.  It has been estimated that about 30-
40 % of all types of cancer can be prevented by proper diet consumption and 
physical activity in a project funded by the American Institute for Cancer Research 
and the World Cancer Research (WCRF/AICR, 1997). 
 
 
In the year 2015 alone, it is estimated that about 1,658,370 new cancer cases 
and 589,430 Americans will die from cancer, corresponding to about 1,640 deaths 
per day (American cancer society. Cancer Facts & Fig.s 2015).  According to the 
survey of the world health organization, global cancer rates could increase by 50% in 
the year 2020, which is approximately to 15 million. Cancers of the lung and 
bronchus, prostate, and colorectal continue to be the most common causes of cancer 
death. In particular, colon cancer claims to be the third most common type of cancer 
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(World Cancer Report 2014.WHO). The American Cancer Society's estimates 
93,090 new cases and 49,700 deaths due to colorectal cancer in the United States for 
2015 (American cancer society. Cancer Facts & Fig.s 2015). The survival of this 
chronic disease is very dependent primarily on the stage of diagnosis, type of cancer 
diagnosed, choice of treatment and comorbidities, as opposed to differences in cancer 
biology. Cancer statistics often focuses on the Five-year survival rate, yet there is no 
clear information that the cancer survivors are still undergoing treatment for these 
five years or cancer free. 
 
 
However, the technological development offers countless choices of 
treatments for cancer patients diagnosed with cancer. The prime ones include 
surgery, chemotherapy and radiotherapy (Rebecca et al., 2014). The selection of 
treatment depends upon the type, location and stage of the cancer as well as the 
person's health and wishes. Chemotherapy is one of the standardized treatments that 
employ chemotherapeutic agents to kill cells that divide rapidly (Lind, 2008). 
Chemotherapeutic drugs induce apoptosis, which is a programmed cell death 
involving biochemical events leading to morphological and molecular changes 
leading to death, in the cancer cells. The basic flow of chemotherapy is shown in 
Figure 1.1.  
 
 
Although there are plenty of drugs, which can retard the cancer, it cannot cure 
cancer completely when detected at the latter stages. Apart from this, there are other 
side effects due to the administration of anticancer drugs. Hence, there is a prolonged 
search for novel anticancer drugs. Scientists not only focus on the synthetic drugs, 
but also the natural compounds from our diets are widely experimented.  
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Figure 1.1 Basics of cancerous growth and chemotherapy 
 
 
The colon cancer commonly develops from the epithelial cells that line the 
colon and rectum regions of the gastrointestinal tract. It is due to the conversion of 
the normal functioning colonic epithelium to adenomatous polyps. Its etiology is 
known to be a combination of hereditary, environmental, dietary factors and lack of 
physical activity (Mordechai et al., 1995). There are several anticancer agents such 
as 5-fluorouracil, folinic acid, oxaliplatin available for treating colon cancer. These 
agents exert their effect by inducing apoptosis of the colon cancer cells. Various lines 
of evidence suggest that apoptosis provides a protective mechanism against neoplasia 
by removing genetically damaged stem cells from the epithelium before they can 
undergo clonal expansion.  
 
 
Some compounds present in our diet were found to have this anticancer 
property. These compounds are naturally occurring and can be easily consumed. 
These dietary compounds include flavonoids and phenolic compounds (Johnson., 
2002). Moreover, the locality of colon cancer in the gastrointestinal track makes it 
more susceptible to these dietary compounds. In this scenario, research communities 
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explore more diet-derived compounds to treat colon cancer as the lining epithelial 
cells are chronically exposed to these dietary agents (Reynolds et al., 1991).   
 
 
Gallic acid (GA) is one such diet-derived phenolic substance being constantly 
surveyed. GA is a type of phenolic organic compound found in many plants and food 
substances. GA is found both free as well as part of hydrolyzable tannins and can be 
easily freed from gallotannins by oxidation (Stein et al., 2011). Literatures have 
demonstrated a range of biological activities of GA. These biological properties 
include anti-fungal, anti-viral, anti-oxidant protecting the cells from oxidative 
damage, cytotoxicity against colon cancer cells without harming the healthy cells 
(Locatelli et al., 2011). Besides, GA is used as a remote astringent for internal 
haemorrhage, albuminuria and diabetes. With respect to the anticancer property, 
numerous in vitro assays have shown that the GA and its derivatives are active 
against several types of tumor cells (Subramanian et al., 2015).  
 
 
Particularly, these studies show that GA induced cell death in colon cancer 
lines COLO 205, HCT 15, HCT 116 (Inoue et al., 1995). However, the mechanism 
induced by GA against colon cancer is not yet elucidated. Thus, this research 
proposes to study the activity of GA against HCT-15 colon cancer cells as well as, 
intends to find the different events associated with apoptotic effect of GA in HCT-15 
colon cancer cells.  
 
 
 
 
1.2  Statement of the Problem 
 
 
According to the statistics, colon cancer is one of the leading causes of death 
in the world. Anyhow, the United States is not left alone as this problem extends its 
tentacles even in Asian countries. Hence, historically low-incidence Asian countries 
are embarking themselves as one of the leaders in this cause. Malaysia is not an 
exceptional case and there is a growing statistics of people affected with colon 
cancer. According to the National Cancer Registry of Malaysia (NCR) records shows 
21,773 Malaysians being diagnosed with cancer but estimates that almost 10,000 
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cases are unregistered every year. Further, colorectal cancer claims to be the second 
most common cancer affecting about 2,900 Malaysians each year, mostly above the 
age of 50 (Quick facts of National Cancer Registry of Malaysia, 
http://www.cancer.org.my/quick-facts/types-cancer/). Chemotherapy is one of the 
common choices of treatment followed by the patients all around the world. Even 
though several anticancer drugs are available for colon cancer, there is no single 
drug, which can effectively cure colon cancer at all stages. Apart from this, they also 
exhibit some other side effects after administration. These factors persuade scientists 
to continuously search for a novel anticancer drug. 
 
 
All types of cancers are said to have link between the diets we consume. In 
case of colon cancer, diet plays a major role as the colonic epithelial cells are 
exposed to diets directly. Because of this reason, scientists explore various natural 
compounds present in food substances to treat colon cancer. Some studies have 
already shown that these natural compounds are absorbed by the body and have 
potential to reduce the risk of colon cancer. The current study deals with examining 
the growth inhibitory effect of the dietary phenolic phytochemical GA against HCT-
15 colon cancer cells as well as on promoting it as a promising candidate in colon 
cancer treatment. 
 
 
 
 
1.3 Objectives 
 
 
The objectives of the research may be enlisted as follows:  
 
 
1.  To determine the effect of GA against HCT-15 colon cancer cells.  
2.  To evaluate the events associated with GA induced apoptosis in HCT-15 
colon cancer cells. 
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1.4 Scope of Study 
 
 
The first part of the study deals with evaluating the effect of GA against 
colon cancer cell line HCT-15. The HCT-15 colon cancer cells are cultured and 
treated with GA. The reaction induced by the GA treatment in HCT-15 cells is 
assessed by MTT assay and cell cycle analysis. Along with this, the ability of GA to 
interrupt the colony formation of HCT-15 is also tested.  
 
 
The final part of the study deals with determining the various events induced 
by GA in HCT-15 cells. This is achieved by mentoring the mitochondrial membrane 
potential fluctuation, estimation of lipid layer organization and determination of 
reactive oxygen species (ROS) level generated. Finally, the occurrence of apoptosis 
is confirmed by Yo-Pro-1 staining. The Figure 1.2 shows the scope of the study.  
 
 
 
 
 
Figure 1.2 Scope of the study 
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1.5 Significance of Study 
 
 
The study gives a possibility for the phenolic compound GA to be employed 
in the treatment of colon cancer cells. The outcome may suggest that GA inhibits the 
growth of colon cancer cells by inducing apoptosis through ROS generation. Hence, 
this research will afford a new drug to be used in treating colon cancer. As GA is a 
compound available in the diets that we consume, the various toxic effects exhibited 
by the currently available anticancer drugs may be avoided. However, further 
experiments in preclinical and clinical settings might promote this for medication to 
cure of colon cancer. 
 
 
Apart from this, GA may be tested for its effect in combination with other 
chemotherapeutic drugs available. More molecular level studies in this field would 
provide ways to combine GA with other drugs already known to be active against 
colorectal cancer, such as irinotecan and oxaliplatin, (Wheate et al., 2010) and 
improve their effectiveness. Further, it may also lead a way to utilize GA as a 
potential candidate in drug resistance reversal of colon cancer cells. 
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